Dysfunctional Red Blood Cells in Children Identified as a Potential Root Cause of Lupus
Research Funded by the Lupus Research Alliance Published in Today’s "Cell"
NEW YORK, NY August 11, 2021. Pediatric lupus expert...
type I interferon
Positive Early Results for BIIB059 as New Treatment Strategy
February 28, 2019
Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
Neovacs Announces the Results of its Phase IIb Study for Ifnalpha Kinoid in the Treatment of Lupus Which Allows to Proceed With the Clinical Development into Phase III
July 3, 2018
Neovacs announced the results of its Phase IIb clinical trial of the investigational agent IFNalpha Kinoid in...